Applications published 25 July 2007

Novel compsn for easing human child birth
HCB Happy Child Birth Holding 1809239*

Cardiac safe, rapid medication delivery
Alexza Pharmaceuticals 1809240*

Dye-free pharmaceutical suspensions and related methods
McNeil-PPC 1809241*

Ophthalmic solution
Advanced Medical Optics 1809242*

Aerosol suspension formulations containing TG277EA or TG134A as a propellant
Boehringer Ingelheim International 1809243*

Retinoid solutions and formulations made therefrom
Imaginative Research Associates 1809244*

Therapeutic liposomes
Gilead Sciences 1809245*

Method of insertion of a lipid-linked moiety into a pre-formed lipid assembly using microwaves
Alza Corp 1809246*

Pharmaceutical dosage forms of stable amorphous rapamycin-like compounds
Cordis 1809247*

Process for granulating particles
Merck; Merck Frosst Canada 1809248*

Multiparticulates of preferably an opioid, and method of manufacturing using extrusion
Euroceltique 1809249*

Due-free pharmaceutical suspensions comprising sorbitol as a non-reducing sweetener and at least one active agent
McNeil-PPC 1809250*

Taste-masked multiparticulate pharmaceutical compsns containing a drug-containing core particle and a solvent coacervated membrane
Eurand Pharmaceuticals 1809252*

Particles for treatment of pulmonary infection
Presidents and Fellows of Harvard College 1809252*

Stabilised freeze-dried formulation for cephalosporin derivatives
Basilea Pharmaceutica 1809253*

Lyophilised liposome formulations and method
Alza Corp 1809254*

High-dosage extended-release formulation of gepirone
Fabre-Krame Pharmaceuticals 1809255*

Dosage forms having a microreliefed surface and methods and apparatus for their production
McNeil-PPC 1809256*

Dosage forms having a microreliefed surface and methods and apparatus for their production
McNeil-PPC 1809257*

Dosage forms having a microreliefed surface and methods and apparatus for their production
McNeil-PPC 1809258*

Less abusable pharmaceutical preparations
Supernus Pharmaceuticals 1809259*

Aqueous pharmaceutical coating
Rubison Research Private 1809260*

Non-gelatin soft capsule system
RP Scherer Technologies 1809261*

New modified release tablet formulation for proton pump inhibitors
AstraZeneca 1809262*

New modified release pellet formulations for proton pump inhibitors
AstraZeneca 1809263*

Antimicrobial amorphous compsns
Acrymed 1809264*

Methods for the treatment of synucleinopathies
The Brigham & Women's Hospital 1809265*

Anticancer compounds and methods
The Regents of the University of Michigan 1809266*

Pharmaceutical compsns based on NK2 antagonists
Laboratoires Guidotti 1809267*

The use of caryophyllenes in the manufacture of medicaments and treatment of bodily conditions of inflammation and inflammatory pain
Ach. Laborat Rios Farmac Uticos 1809268*

Sugars and/or sugar alcohols for inhibiting and/or treating vaginal infection
Kimberley-Clark Worldwide 1809269*

5,6,7-trihydroxyheptanoic acid and analogues for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses
Alcon 1809270*

(Halobenzyloxy) benzylamino-propanamirs as sodium and/or calcium channel selective modulators
Newton Pharmaceuticals 1809271*

Methods and compsns for treatment of free radical injury
Maroon Biotech Corp 1809272*

Use of 2-phenyl-1,2-ethanediol-(DI) carbamates for treatment epileptogenesis and epilepsy
Janssen Pharmaceutica 1809273*

Pharmaceutical compsn for rectal or vaginal application comprising a platinum complex
Pliva-Lachema 1809274*

Chemical compounds
SmithKline Beecham 1809275*

Treatment method
Ariad Gene Therapeutics 1809276*

Phosphonate derivatives of mycophenolic acid
Gilead Sciences; Watkins, William; Cho, Aesop 1809277*

Combinations of PKC activators and PKC inhibitors for Alzheimer's diseases treatment and cognitive enhancement
Blanchette Rockefeller Neurosciences Institute 1809278*

Nanoparticulate compsns of tubulin inhibitor
Baxter International; Baxter Healthcare 1809279*

Mitotic kinesin inhibitors and methods of use thereof
Array Biopharma 1809280*

Use of epithilones in the treatment of bone metastases and bone tumours or cancers
Bayer Schering Pharma 1809281*

Thiadiazole compounds and methods of use
Amgen 1809282*

Morphine and morphine precursors
The Research Foundation of the State University of New York 1809283*

Niacin receptor agonists, compsns containing such compounds and methods of treatment
Merck 1809284*

Combinations of nicotinic acetylcholine alpha 7 receptor agonists
Novartis; Novartis-Pharma 1809285*

Method of treatment of movement disorders
The Trustees of Columbia University in the City of New York 1809286*

Multiple layer coating compsn
CABG Medical 1809287*

Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
Institut National de la Sante et de la Recherche Medicale; Universite du Droit et de la Sante 1809288*

Use of ranolazine in combination with at least one remodelling agent for reversing left ventricular remodelling in the treatment of heart failure
CV Therapeutics 1809289*

Pyrimidine derivatives as ion channel modulators and methods of use
Vertex Pharmaceuticals 1809290*

Pharmaceutical compsns for transdermal delivery
Forhumantech 1809291*

Condensed pyrimidine derivatives as inhibitors of folic acid-dependent enzymes
Stoicescu, Dan 1809292*

Aerosol formulation for inhalation of beta agonists
Boehringer Ingelheim International 1809293*

Compounds for inflammation and immune-related uses
Synta Pharmaceuticals 1809294*

Novel formulations of eprosartan with enhanced bioavailability
Derray Technology 1809295*

Novel [1,4]benzodiazepines as vasopressin V2 receptor antagonists
Janssen Pharmaceutica 1809296*

Imidazo[1,5A]triazolo[1,5D]benzodiazepine derivatives for the treatment of cognitive disorders
F Hoffmann-La Roche 1809297*

Neuroprotective spirostenol pharmaceutical compsns
Georgetown University; Samaritan Pharmaceuticals; Yao, Zhi-Xing; Teper, Gary; Papadopoulos, Vassilios 1809298*

Phosphonate substituted kinase inhibitors
Gilead Sciences 1809299*

Method for treating bacterial infections in horses or pigs with tilmicosin
Idexx Laboratories 1809300*

Preparation of 2"fluoro-2"-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
Pharmasset 1809301*

Antisens modulation of integrin alpha-4 expression
Antisense Therapeutics 1809302*

Pharmaceutical compsns and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
Arc Pharmaceuticals 1809303*

Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compsns
Procter & Gamble 1809304*

Phosphate binder with reduced pill burden
Altairnano 1809305*

Copper containing materials for treating wounds, burns and other skin conditions
Cupron 1809306*

Medical solution, method for producing and use thereof
Gambro Lundia 1809307*

Topical compsns comprising myrica gale ointment
The Boots Co 1809309*

Bioactive wound dressings and implantable devices and methods of use
Medivas 1809310*

Penetrating carrier, anti-fungal compsn using the same and method for treatment of dermatophytes
Selner Marc 1809311*

Use of 11-OH-erythravine, erythravine, pharmaceutical compsns and processes for producing these substances
Universidae Estudual Paulista Julio de Mesquita Filho-Unesp 1809312*

Method to promote wound healing
ImmuneRegen BioSciences 1809313*

Class III SLRP for the treatment of cancer
The University of Manchester 1809314*

Inhibition of tumour growth and metastasis by AFT2-derived peptides
The Mount Sinai School of Medicine of New York University 1809315*

Use of survivin to treat kidney failure
VIB 1809316*

Method and pharmaceutical compsn for preventing or treating diseases associated with inflammation
Kyungpook National University Industry-Academic Cooperation Foundation 1809317*

Anti-respiratory syncytial virus antibodies, antigens and uses thereof
Centocor 1809319*

Compsns containing lipase; protease and mylase for treating pancreatic insufficiency
Altus Pharmaceuticals 1809320*

Process for obtention of new cellular pertussis vaccine
Fundacao Butantan 1809323*

Methods to treat or prevent viral associated lymphoproliferative disorders
The Ohio State University Research Foundation 1809324*

Sustained local anaesthetic compsn containing preferably a sugar ester such as SAIB
Durect 1809329*

Methods and compsns for reducing toxicity of a pharmaceutical compound
Yoo, See Hong 1809330*

Transepithelial delivery of peptides with incretin hormone activities
Nitto Denko 1809331*